IL6 and rheumatoid arthritis: IL-17, in addition to provoking the production of pro-inflammatory cytokines IL-6 among others; also encourages Th17 immune cell differentiation, a pro-inflammatory immune pathway, which in patients with RA increases RANKL expression and subsequent osteoclastic activity [17].